Format

Send to

Choose Destination
Altern Lab Anim. 2003 May-Jun;31(3):273-6.

Refining in vitro neurotoxicity testing--the development of blood-brain barrier models.

Author information

1
Cell Research Centre, Medical School, University of Tampere, 33014 Tampere, Finland.

Abstract

The purpose of this paper is to review the current state of development of advanced in vitro blood-brain barrier (BBB) models. The BBB is a special capillary bed that separates the blood from the central nervous system (CNS) parenchyma. Astrocytes maintain the integrity of the BBB, and, without astrocytic contacts, isolated brain capillary endothelial cells in culture lose their barrier characteristics. Therefore, when developing in vitro BBB models, it is important to add astrocytic factors into the culture system. Recently, novel filter techniques and co-culture methods have made it possible to develop models which resemble the in vivo functions of the BBB in an effective way. With a BBB model, kinetic factors can be added into the in vitro batteries used for evaluating the neurotoxic potential of chemicals. The in vitro BBB model also represents a useful tool for the in vitro prediction of the BBB permeability of drugs, and offers the possibility to scan a large number of drugs for their potential to enter the CNS. Cultured monolayers of brain endothelial cell lines or selected epithelial cell lines, combined with astrocyte and neuron cultures, form a novel three-dimensional technique for the screening of neurotoxic compounds.

PMID:
15612870
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Fund for the Replacement of Animals in Medical Experiments (FRAME)
Loading ...
Support Center